Table 3:
Number and percentage of patients with an ACR20 response, together with the number of patients with a 20% improvement for each core variable. 20 after each variable indicates 20% improvement.
Variable
Placebo (
)
Active (
)
Placebo-active
value
Number
%
Number
%
Difference %
95% CI
ACR20
0
0
2
17
−17
−38 to 4
.5
Completed
8
100
7
58
42
14 to 70
.06
HAQ20
0
0
2
17
−17
−38 to 4
.5
VAS Assess.20
5
63
4
33
29
−14 to 72
.4
Pat. Pain20
1
13
3
25
−13
−46 to 21
.6
Pat. Dis. Assess.20
1
13
2
17
−4
−35 to 27
1.0
CRP20
3
38
4
33
4
−39 to 47
1.0
ESR20
5
63
1
8
54
17 to 91
.02
Swollen joint20
4
50
6
50
0
−45 to 45
1.0
Tender joint20
6
75
6
50
25
−16 to 66
.4